Cargando…
Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports
Cutaneous adverse events to dupilumab can be varied; this necessitates keeping a broad differential diagnosis to identify seemingly paradoxical reactions. It may be possible to treat the adverse event concurrently without stopping dupilumab.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455398/ https://www.ncbi.nlm.nih.gov/pubmed/32884774 http://dx.doi.org/10.1002/ccr3.2871 |
| _version_ | 1783575616027623424 |
|---|---|
| author | Al‐Janabi, Ali Marsland, Alexander M. |
| author_facet | Al‐Janabi, Ali Marsland, Alexander M. |
| author_sort | Al‐Janabi, Ali |
| collection | PubMed |
| description | Cutaneous adverse events to dupilumab can be varied; this necessitates keeping a broad differential diagnosis to identify seemingly paradoxical reactions. It may be possible to treat the adverse event concurrently without stopping dupilumab. |
| format | Online Article Text |
| id | pubmed-7455398 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74553982020-09-02 Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports Al‐Janabi, Ali Marsland, Alexander M. Clin Case Rep Case Reports Cutaneous adverse events to dupilumab can be varied; this necessitates keeping a broad differential diagnosis to identify seemingly paradoxical reactions. It may be possible to treat the adverse event concurrently without stopping dupilumab. John Wiley and Sons Inc. 2020-05-09 /pmc/articles/PMC7455398/ /pubmed/32884774 http://dx.doi.org/10.1002/ccr3.2871 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Case Reports Al‐Janabi, Ali Marsland, Alexander M. Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports |
| title | Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports |
| title_full | Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports |
| title_fullStr | Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports |
| title_full_unstemmed | Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports |
| title_short | Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports |
| title_sort | seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: two case reports |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455398/ https://www.ncbi.nlm.nih.gov/pubmed/32884774 http://dx.doi.org/10.1002/ccr3.2871 |
| work_keys_str_mv | AT aljanabiali seborrhoeicdermatitisandsebopsoriasisdevelopinginpatientsondupilumabtwocasereports AT marslandalexanderm seborrhoeicdermatitisandsebopsoriasisdevelopinginpatientsondupilumabtwocasereports |